DMAC
DiaMedica Therapeutics Inc

1,557
Mkt Cap
$437.45M
Volume
66,304.00
52W High
$10.42
52W Low
$3.19
PE Ratio
-11.71
DMAC Fundamentals
Price
$8.15
Prev Close
$8.40
Open
$8.37
50D MA
$8.40
Beta
1.20
Avg. Volume
251,500.85
EPS (Annual)
-$0.605
P/B
8.47
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Short Interest in DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Declines By 22.8%
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke...
Business Wire·19d ago
News Placeholder
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of "Moderate Buy" from Brokerages
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven brokerages that are covering the company, MarketBeat.com reports...
MarketBeat·22d ago
News Placeholder
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat...
MarketBeat·2mo ago
News Placeholder
DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4% - Here's Why
DiaMedica Therapeutics (NASDAQ:DMAC) Shares Up 7.4% - Here's Why...
MarketBeat·2mo ago
News Placeholder
DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year High - Time to Buy?
DiaMedica Therapeutics (NASDAQ:DMAC) Hits New 1-Year High - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
Jan Stahlberg Buys 128,426 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of the business's stock in a transaction that occurred on Thursday, November 20th...
MarketBeat·2mo ago
News Placeholder
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,221,802.36 in Stock
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 187,393 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The...
MarketBeat·2mo ago
News Placeholder
Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 208,872 shares of the business's stock in a transaction dated Friday, November 21st. The stock was...
MarketBeat·2mo ago
News Placeholder
Jan Stahlberg Acquires 240,352 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 240,352 shares of the firm's stock in a transaction on Wednesday, November 19th. The stock was...
MarketBeat·2mo ago
<
1
2
...
>

Latest DMAC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.